CGFA
RVMD icon

Colton Groome Financial Advisors’s Revolution Medicines RVMD Stock Holding History

Colton Groome Financial Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$411K Hold
2,000
– – 0.1% 106
2026
Q2 		$375K Buy
+2,000
New +$292K 0.09% 114

Other funds holding RVMD

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
BFS
Burkett Financial Services Rock Hill, South Carolina $331M AUM 14.93% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Colton Groome Financial Advisors's RVMD Position: Q3 2026 in Review

Colton Groome Financial Advisors held its Revolution Medicines (RVMD) position steady in Q3 2026 at 2,000 shares worth $411K. The position accounts for 0.1% of the portfolio, ranked #106.

Colton Groome Financial Advisors first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Colton Groome Financial Advisors held 2,000 shares of Revolution Medicines worth $411K as of Q3 2026.
  • Colton Groome Financial Advisors left its Revolution Medicines share count unchanged in Q3 2026.
  • Revolution Medicines made up 0.1% of Colton Groome Financial Advisors's portfolio in Q3 2026, its #106 holding.
  • Colton Groome Financial Advisors first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Colton Groome Financial Advisors's 13F filing for Q3 2026, filed 6 Oct 2026.